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Attempts to promote normal processing and function of F508del-CFTR, the most
common mutant in cystic fibrosis (CF), have been described as potential thera-
peutic strategies in the management of this disease.
Here we described the proteomic approaches, namely two-dimensional elec-
trophoresis (2DE), mass spectrometry (MS), and bioinformatics tools used in
our recent studies to gain insight into the proteins potentially involved in low-
temperature or mutagenic treatment-induced rescue process of F508del-CFTR.
The proteins identified are part of the proteostasis network, such as
the unfolded protein response (UPR) signaling pathways that may regulate the
processing of CF transmembrane conductance regulator (CFTR) through
the folding and trafficking progression. The complete characterization of these
signaling pathways and their regulators in CF will certainly contribute to
the development of novel therapeutic strategies against CF.1. Introduction
The unfolded protein response (UPR) is one of the signaling pathways
composing the proteostasis network, which regulates and maintains the
protein folding and function in the face of many cellular challenges during
cell lifetime (Powers et al., 2009). The UPR is a complex molecular cascade
activated in response to cellular stressors that induce the endoplasmic
reticulum (ER) overloading with unfolded proteins. The UPR is mainly
characterized by upregulation of ER chaperones to improve the folding
capacity of the ER and reestablish ER homeostasis, by facilitating proteins
correct folding or assembly and preventing protein aggregation in the ER
lumen and consequently improving cell survival (Citterio et al., 2008;
Kelsen et al., 2008). Activation of ER-associated degradation (ERAD)
pathways, another signaling pathways composing proteostasis network
responsible for the degradation of the excess of misfolded proteins in the
ER (van Anken and Braakman, 2005), is also a characteristic feature
of UPR.
Dysregulation of cellular proteostasis by a constant flux of misfolded and
mistrafficking proteins contributes to a broad range of human diseases such
as cystic fibrosis (CF).
CF is mostly caused by the inherited F508del mutation that leads to CF
transmembrane conductance regulator (CFTR) misfolding and excessive
degradation, ultimately resulting in reduced availability of functional
protein.
Under F508del-CFTR overexpression, cells induce ER stress and/or
the UPR signaling pathways as a response to a loss of proteostatic control
(Bartoszewski et al., 2008; Gomes-Alves and Penque, 2010; Gomes-Alves
UPR/ER Stress Signalling Pathways Unraveled by Proteomics 219et al., 2009, 2010a; Kerbiriou et al., 2007). We have shown by proteomics
that treatments aimed at rescuing F508del-CFTR, such as low-temperature
incubation or “RXR” mutagenic repair (by inactivation of four RXR
motifs of F508del-CFTR-4RK mutant), modulate/readjust the proteome
components of pathways composing proteostasis network, including the
UPR and ERAD (Gomes-Alves and Penque, 2010; Gomes-Alves et al.,
2009, 2010a).
Most therapies designed to rescue the trafficking defect of F508del-
CFTR cause the UPR/ER stress induction (Gomes-Alves et al., 2010b;
Loo et al., 2005; Singh et al., 2008) involving, however, a larger number or
higher expression of proteins than those induced by the misfolded protein
itself (Gomes-Alves and Penque, 2010; Gomes-Alves et al., 2010b; Loo
et al., 2005; Singh et al., 2008). This treatment-induced UPR/ER stress
stimulus seems also to readjust some proteostasis imbalance associated with
F508del-CFTR expression, which probably endows the cell with the
ability to rescue at least partially the mutant CFTR.
We showed that overexpression in BHK cell lines of “repaired” form of
F508del-CFTR, F508del-4RK-CFTR, or low-temperature treatment on
BHK cell lines overexpressing the mutant F508del-CFTR induce upregu-
lation of GRP78/BiP (the UPR hallmarker), several ER stress (e.g.,
GRP94 and GRP75), and several foldases (e.g., PDI) and readjust (to wt
type level) some proteome imbalance associated with the proteosome
degradation (e.g., Psme2 and Cops5) and folding and transport (e.g.,
RACK1) of CFTR (Gomes-Alves and Penque, 2010; Gomes-Alves et al.,
2009, 2010a).
We are convinced that the complete characterization of the proteostasis
signaling pathways and their regulators in CF by high-throughput proteo-
mics will confidently culminate in the development of novel therapeutic
strategies against CF.2. 2DE-Based Proteomics Approach Analysis to
Study Protein Expression Profile
Proteome profiling of cells/tissues under different conditions (e.g.,
health vs. disease, treated vs. nontreated) by two-dimensional gel electro-
phoresis (2DE) and mass spectrometry (MS)-based proteomic approach has
contributed to the elucidation of the basic cellular mechanisms of disease by
discovering candidate biomarkers and disease targets for new drug develop-
ment (Penque, 2009).
The main advantage of 2DE technology is its capacity to provide a global
view of a sample proteome at a given time by resolving hundreds to
thousands of proteins simultaneously on a single gel. In spite of the inability
220 Patrı´cia Gomes-Alves et al.of 2DE to resolve all proteins present in a sample (e.g., highly hydrophobic
proteins, low abundance proteins, extremely basic or acidic pI values,
molecular size out of gel limits) or the growing developments in gel-free
MS-based approaches, 2DE in combination with MS still remains the most
popular technology in proteomics (Penque, 2009).
In the next sections we provide detailed information on the optimal
conditions and procedures for 2DE/MS-based proteomics analysis used in
our previous publications (Gomes-Alves and Penque, 2010; Gomes-Alves
et al., 2009), as an approach able to uncover cellular mechanisms involved
on treatments-induced mistrafficking protein rescue.3. Experimental Design
3.1. Cell lines
The importance of using recombinant CFTR-expressing cell lines as heter-
ologous model systems is recognized from previous studies (Chang et al.,
1999; Mendes et al., 2003; Roxo-Rosa et al., 2006), since endogenous
CFTR-expressing models are limited and the expression level is usually
too low to study CFTR biogenesis, trafficking and function.
Adherent cell lines, such as BHK cells, not expressing (BHK-L) or stably
expressing wild type (wt)-, F508del-CFTR (mutant), or F508del/4RK-
CFTR (“repaired”) are cultivated in DMEM/F12 media containing 5%
fetal calf serum (Gibco, Invitrogen) and 500 mM methotrexate (MTX—
Teva Pharma) in culture flasks (Nunc Prand Products) until 80% of conflu-
ence (Roxo-Rosa et al., 2006). Cells are then trypsinized and washed once
in PBS (Gibco, Invitrogen) and pellets with 5  106 cells should be quickly
frozen on dry ice and stored at 80 C until analysis. All BHK cell lines
were provided by Roxo-Rosa et al. (2006).3.2. Low-temperature treatment and in vivo labeling
Low temperature (26–30 C) apparently stabilizes the mutant protein
during folding in the ER, allowing some CFTR molecules to escape ER
quality control and traffic through the Golgi apparatus to the plasma
membrane (Denning et al., 1992; Mendes et al., 2003; Sharma et al.,
2001). Alternatively, Rennolds et al. (2008) have suggested that at low-
temperature, F508del-CFTR may use a nonconventional trafficking path-
way and bypasses the Golgi apparatus where CFTR becomes Endo-H
resistant.
To investigate the effect of low temperature in the proteostasis environ-
ment involved in F508del-CFTR rescue, 6  105 BHK cells stably expres-
sing wild type (wt)- or F508del-CFTR should be seeded per 35 mm culture
UPR/ER Stress Signalling Pathways Unraveled by Proteomics 221dishes (Nunc Prand Products), grown to about 80% of confluence and then
incubated at 37 C (control) or 26 C for 24 or 48 h in the same media
without MTX. Cells are incubated 30 min in methionine-free a-minimal
essential medium (MEM, Gibco, Invitrogen) prior to the metabolic labeling
in the same medium with 140 mCi/ml of [35S]-methionine (MP Biome-
dicals), in the last 3 h of incubation at 37 or 26 C, respectively.
The 3-h cell metabolic labeling allows the visualization of proteins that
are synthesized and further processed during this time of incubation with
the [35S]-methionine (de novo synthesis—visualization of treatment effects
on protein synthesis), while Coomassie staining allows the visualization of
all proteins at steady state present in the sample.4. 2D Gel Electrophoresis
4.1. Sample preparation
Pellets of 5  106 (or 0.8  106 for radiolabeled cells) cells are lysed
directly in 450 ml of lysis buffer [7 M urea (Sigma-Aldrich), 2 M thiourea
(Sigma-Aldrich), 4% (w/v) CHAPS (Sigma-Aldrich), 60 mMDTE (Sigma-
Aldrich), 0.75% (v/v) ampholine 3.5–10.0 (GE Healthcare), 0.25% (v/v)
ampholine 4.0–6.0 (GE Healthcare)], and 0.12 ml of protease inhibitor
mixture (leupectin 1 mg/ml; aprotinin 2 mg/ml; pefabloc 50 mg/ml; E64
3.5 mg/ml; benzamidin 50 mg/ml). After 30 min at 37 C rocking, samples
are sonicated three times 15 s in a waterbath sonifier (Selecta) and then
clarified by centrifugation at 14,000g for 30 min. Supernatants are col-
lected for a new microtube.4.2. 2D-PAGE
In the first dimension of 2DE (isoelectric focusing, IEF), proteins are
separated on the basis of their isoelectric point in an immobilized pH
gradient gel (IPG) and in the second-dimension (SDS-PAGE) proteins
undergo an additional separation according to their molecular weight
under denaturing conditions. There are different 2DE methodologies or
possibilities and all require the use of biological and technical replicates to
produce meaningful results (Penque, 2009). A guidelines called MIAPE
(Minimum Information About Proteomics Experiments) gel electrophore-
sis that act as checklists of the essential information that should be reported
about particular 2DE experimental techniques has been also recently created
(http://psidev.sourceforge.net) (see below).
In our 2DE procedure, total extracted protein samples (supernatants) are
loaded onto 18 cm Immobiline DryStrips (GE Healthcare) with a nonlinear
wide range pH gradient (pH 3–10) with a top overlay of 3 ml of mineral oil
222 Patrı´cia Gomes-Alves et al.(Amershan Bioscience) to prevent evaporation and urea crystallization
during next steps of IEF on an IPGphor IEF system (Amershan Bioscience).
For IEF, an active rehydration at 50 V for at least 12 h at 20 C is performed
before the focusing program of a total of about 60 kVh as follows: 200 V for
1 h, 500 V for 1 h, 1000 V for 2 h, 2000 V for 2 h, 3000 V for 2 h, increased
gradient voltage to 8000 V for 1 h, and 8000 V for 5 h. After IEF is run, IPG
strips were equilibrated in IEF equilibration solution (50 mM Tris–HCl, pH
8.8 (Merck), 6 M urea (Sigma-Aldrich), 30% (v/v) glycerol (Sigma-
Aldrich), 2% (w/v) sodium dodecyl sulfate (SDS) (GE Healthcare), and
traces of bromophenol blue (Merck) with 2% (w/v) DTE (Sigma-Aldrich)
for 15 min and with 2.8% (w/v) iodoacetamide (Sigma-Aldrich) for another
15 min, to, respectively, reduce and alkylate proteins before application
onto the top of a SDS-PAGE for molecular weight separation (second
dimension), constituted by 8–16% (w/v) gradient polyacrylamide and run
overnight at 3W/gel (Ettan DALTwelve System, GEHealthcare). The strip
gels are “glued” onto the top of a SDS-PAGE with boiled 0.5% (w/v)
agarose in running buffer. If the second dimension is not carried out imme-
diately after IEF, strips can be stored for prolonged times at 80 C.4.3. Coomassie and fluorography
Proteins once displayed on the 2D gel must be visualized in a valuable form
to enable their accurate qualitative/quantitative analysis by dedicated soft-
ware. The critical factors of staining methods are their sensitivity, repro-
ducibility and the linear range of detection. The most used standard
procedures of protein staining include Coomassie brilliant blue (CBB),
and variants such as colloidal CBB (C-CBB) or blue silver (C-CBB mod-
ified), and MS-compatible silver stain (Gorg et al., 2004). Other choices
include DIGE (difference gel electrophoresis), SYPROÒRuby (fluorescent
dyes), or radiolabeling (e.g., 35S-methionine or 32P-phosphorous) (Minden,
2007; Roxo-Rosa et al., 2004).
As referred before in Section 3.2, the proteins labeled in vivo with [35S]-
methionine are visualized by autoradiography as follows: the gel is fixed in
30% (v/v) methanol and 10% (v/v) acetic acid for 30 min, washed four
times 15 min in water, and treated for 1 h with 1MNa salicylate, pH 7. The
gels are then dried in a vacuum system for 2 h at 80 C and film exposed
(Fuji Film) with intensifying screen. “Cold” proteins (without radiolabel-
ing) are visualized by Coomassie “blue silver” staining exactly as described
(Candiano et al., 2004).
Metabolic labeling is much more sensitive [<0.1–0.01 ng (Penque,
2009)] than the “blue silver” Coomassie (detection limit 1–100 ng/spot)
(Candiano et al., 2004). Moreover, [35S]-methionine labeling detects the
presence of a number of proteins that are undetectable by silver staining or
Western blotting (Chen and Casadevall, 1999). The digitalized images from
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proper scanner (obtained image quality attributes must be compatible with
the requests of the analysis software), as for example ImageScanner (GE
Healthcare).4.4. 2D maps image analysis
Subsequent analysis of the spot pattern on a gel by specialized software
enables multiple-gel comparison, whereby quantitative and qualitative
changes are detected by comparison with control gels. The critical parame-
ter in computer-based image analysis is the quality of the images. This
requires high quality and reproducible 2D gels and also high quality acqui-
sition of the image with image capturing devices, as mentioned above.
Image analysis software is designed for automated spot detection, matching,
normalization and quantification. However corrections by user interven-
tion are usually necessary.
In our studies the dedicated software used for gel image analysis was
Progenesis PG200v2006-Nonlinear. An average gel image is created for
each group of gels and a maximum of absences allowed must be defined
(according to the analysis objectives and depending on the gels replica
number). In order to standardize the intensities of the labeling among all
spots present in the several 2DE-maps, analysis is carried out by taking into
account the normalized volume of spots (or %vol., i.e., the volume of each
spot over the volume of all spots in the gel).4.5. Statistical analysis
The difference in expression levels between groups (control, disease, and
treatment) for a given protein is statistically assessed by using the ANOVA
test, for n observations, where n is the number conditions (groups) analyzed.
Differences over 1.5-fold are considered statistically significant when
p < 0.05. Proteins of interest are then selected and excised from gels for
subsequently MS analysis (see below).5. Protein Identification by MS
Two specific types of MS analysis can be used for protein identifica-
tion: the peptide-mass fingerprint (PMF), which involves determination of
the masses of the peptides in the digest and is normally performed in a
MALDI-TOF instrument, and the amino acid sequencing of the peptides
(MS/MS), normally obtained by ESI tandem MS or MALDI-TOF/TOF
(Penque, 2009).
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map or protein sequence within a database to identify the protein of interest
using software such as Sequest (Thermo) or Mascot (MatrixScience)
(Aebersold and Mann, 2003; Steen and Mann, 2004). Using a database
search, candidate proteins are ranked from a list of most closely matched
candidates using various scoring algorithms.5.1. Protein gel cut and digestion
After spot excision from gels, protein spots are distained as follows: wash
spots with type I (Millipore) water for 20 min and then incubate with 50%
(v/v) acetonitrile (ACN) for 30 min, at 37 Cwith shaking. After distaining,
spots are dehydrated by incubation with ACN first for 5 min and further
30 min with fresh ACN, at RT, with shaking. The gel pieces are lyophilized
by a Speedvac evaporator (Savant, Farmingdale, USA) for 30–60 min,
followed by trypsin digestion. For trypsin digestion spots are rehydrated
with digestion buffer containing 6.7 ng/l of trypsin (Promega, Madison,
WI, USA) in 50 mM NH4HCO3 and incubated for 30 min at RT.
Digestion buffer is removed and 50 mM NH4HCO3 is added to the spots,
which are incubated overnight (12–16 h) at 37 C.
After overnight digestion with trypsin, supernatants are collected for
new tubes and extraction of tryptic peptides is performed by successive
incubation of the gel piece with 1% (v/v) TFA/50% (v/v) ACN and with
100% (v/v) ACN. For each step samples are sonified for 10 min in a
waterbath sonifier (Selecta). The respective supernatants are pooled and
dehydrated with a speed vacuum rotor (Savant). The pellet is resuspended in
5 ml of 0.1% (v/v) TFA/50% (v/v) ACN and finally sonified for 15 min in
the waterbath sonifier. The sample (0.5 ml) is spotted on the MALDI plate
and 0.5 ml of a-CHCA are added to the sample, the mixture is allowed to
dry at RT (Bensalem et al., 2007).5.2. MALDI analysis—Equipment and specifications
Peptides are analyzed on an Applied Biosystems 4700 ProteomicsAnalyzer
with TOF/TOF ion optics. Data are acquired in positive MS reflector
mode with six spots of protein standards (Calibration Mixture 2, Applied
Biosystem) used for calibration (4000 Series Explorer Software v3.0 RC1).
Three or five S/N best precursors of each spectrum can be selected for
MS/MS analysis. The interpretation of the MSþMS/MS data is carried out
by the GPS Explorer software (Version 3.5, Applied Biosystems) and a local
copy of the MASCOT search engine (Version 2.0). Monoisotopic peptide-
mass values are considered, a MS mass tolerance is set at 50 ppm and a
MS/MS fragment tolerance set at 0.25 Da. Identification restrictions can be
applied. Trypsin is normally the digestion enzyme used and one missed
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tion are set as fixed and variable amino acid modifications, respectively.
A taxonomic restriction to specific species protein sequences may be
included. For MS all peaks with S/N greater than 5 and for MS/MS all
peaks with S/N greater than 3 are searched against the database (e.g.,
Swissprot, NCBInr, etc.). The criteria to accept the identification are
significant homology scores achieved in Mascot (p < 0.05), but depending
on the goals of the study or on the standards of the journal where the author
wishes to publish, more stringent criteria may be used (e.g., minimum of
matched peptides, minimum of sequence coverage, etc.).6. Biochemical Validation
The generated data from a quantitative proteomics analysis has
required validation/verification that can be performed by traditional bio-
chemical assays (e.g., Western blotting, immunocyto/hystochemistry, or
other) or more recently by MS-based approaches (e.g., selected/multiple
reaction monitoring (SRM/MRM)-based workflows) (Kitteringham et al.,
2009; Picotti et al., 2010)
In our study, Western blot assay using antibodies specific to relevant
proteins is used to validate/verify the proteomic data obtained. Briefly, protein
extracts from cell lines are quantified (Bradford; Bio-Rad protein assay) and
15 mg of each cell sample (triplicates) are separated on NuPAGEÒ Novex 4-
12% (w/v) Bis–Tris gel 1.0 mm, 15 well (Invitrogen), transferred to nitrocel-
lulose membranes (Schleicher & Schuell). After transference, the membranes
are blocked with PBS plus 5% (w/v) fat free milk for 2 h and probed in the
same solution for 2 h at RT with: 1:300 rabbit anti-GRP78/BiP Ab (Sigma-
Aldrich), 1:500 mouse anti-PDI (Santa Cruz Biotechnology), 1:2000 rabbit
anti-GRP94 (Abcam), 1:500 mouse anti-GRP75 (Abcam), 1:1000 rabbit
anti-S100A6 (Abcam), 1:1000 mouse anti-HSP72 (Stressgen); 1:1000
goat anti-Psme2 (Abcam), 1:10000 mouse anti-COPS5 (Abcam) or 1:1000
rabbit anti-RACK1 (Sigma-Aldrich). After three washes of 15 min each with
PBS–0.5% (v/v) Tween 20, membranes were probed with appropriated
secondary antibody, 1:5000 anti-mouse IgG HRP (from sheep) or 1:5000
anti-rabbit IgGHRP (from donkey) (both fromGEHealthcare). The immu-
noreactions are developed on washed membranes as before using enhanced
chemiluminescence-ECL (GE Healthcare).
For Western blots normalization, all membranes are washed with the
stripping buffer [1.5% (w/v) glycine, 0.1% (w/v) SDS; 1% (v/v) Tween 20;
pH 2.2] five times for 10 min, washed with PBS and one last time with
PBS-T, and reprobed as above with 1:1000 mouse anti-a tubulin (Sigma-
Aldrich) and developed using ECL. The abundance of proteins is calculated
226 Patrı´cia Gomes-Alves et al.from densitometry of immunoblots (n ¼ 3 replicates) using the Progenesis
PG200v2006. Figures 13.1 and 13.2 are illustrated examples of 2DE-maps
and validation data obtained for PSME and GRP78/BiP, respectively,
under the different conditions studied.7. Data Mining and Publication
7.1. Bioinformatics analysis
Bioinformatics tools that deal with high-throughput data and allow its
efficient and accurate analysis, interpretation and correlation, have accom-
panied the important progresses in the proteomics field as they are funda-
mental for the continuous development of proteomics technology.
Gene Ontology (GO) (www.geneonthology.org) is used to search for
biological processes, cellular components and molecular functions asso-
ciated to the proteins identified. In order to collect all the availableA
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UPR/ER Stress Signalling Pathways Unraveled by Proteomics 227information about each protein, PIKE (Protein Information and Knowl-
edge Extractor) software can also be used, this bioinformatics tool retrieves a
set of biological information like: gene name, location, tissue specificity,
228 Patrı´cia Gomes-Alves et al.function, GO terms and keywords (http://proteo.cnb.uam.es:8080/pike/)
(see Fig. 13.3A). Protein interactions networks can also be accessed through
web-free software, such as Cytoscape, using available protein–protein interac-
tion databases (http://www.cytoscape.org/).Other commercial available tools
such as Ingenuity Pathway Analysis (Ingenuity Systems Inc.) are able to
retrieve functional biological networkswhere proteins of interest are involved.7.2. Clustering analysis
By hierarchical clustering, a powerful data mining approach for a first
exploration of proteomic data, proteins can be group blindly according to
their expression profiles facilitating their interpretation. The clustering
results depend on parameters such as data preprocessing, between-profile
similarity measurement, and the dendrogram construction procedure—
methodology reviewed elsewhere (Meunier et al., 2007).
In the “low-temperature” study and after the differential protein expres-
sion analysis amongst the six experimental conditions, each spot identified
showing statistical significant difference relative to the BHK-wt 37 C
condition are included in the relationship analysis amongst each other
(columns) and the six phenotypes (rows), using the normalized volume
quantity data.
To avoid distortion in clustering analysis on the account of a small subset
of abundant protein spots, standardization of data is performed using the z-
score calculation Eq. (13.1); where x is the arithmetic mean and s is the
standard deviation, calculated from the volume quantity data for a given
protein spot in the six phenotypes, and x is the individual volume quantity
to be normalized. Special care is taken relating to the missing values in the
six experimental conditions for an identified spot, which are regarded as a
missing spot coloration in 2D gel and as so, interpreted as zero volume
quantity. For a given spot, the null information are first substituted by the x
data in the analyzed phenotypes (column), and then submitted to the
standardization process.
z ¼ x xð Þ 1
s
ð13:1Þ
In order to classify the individual protein spots (columns), and the
phenotypes(rows), according to the global expression profile, a two way
hierarchical clustering analysis can be executed using geWorkbench, ver-
sion 1.5.1 (http://www.geworkbench.org/), a free open source genomic
analysis platform developed at Columbia University with funding from the
NIH Roadmap Initiative (1U54CA121852-01A1) or the National Cancer
Institute. The normalization process is done directly in the platform choos-
ing the option “Mean-variance normalizer,” which was followed by “Fast
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Figure 13.3 Graphical representation of the log normalized volume of proteins in BHK-F508del (A). Expression levels of those proteins in
BHK-F508del at 37 C were considered as reference to determine the up- or downregulation of the correspondent protein in the other
phenotype. Proteins up- and downregulated in F508del cells were also classified according to their molecular function. Unsupervised
hierarchical clustering (Euclidean distances and average linkage) of the expression profiles of the 139 protein spots differentially expressed
in the six phenotypes studied (B). Each horizontal row in the heat map represents the expression level for one protein in the different
phenotypes (columns). The relative abundance is displayed by color intensity (light red—more abundant; light green—less abundant).
UPR/ER Stress Signalling Pathways Unraveled by Proteomics 231Hierarchical Clustering Analysis.” The euclidean distance metrics Eq. (13.2)
was chosen to measure the dissimilarity between the data and the best
agglomerative classification for our data is obtained from “Average
Linkage.”
dðx; yÞ ¼ Si xi  yið Þ2
 1=2 ð13:2Þ
Figure 13.3B shows the output of the geWorkbench, where the two
generated dendograms (protein spots and phenotypes) are linked by a heat
map graph of the standardized data, allowing a better interpretation of the
clustering results.7.3. MIAPE: The Minimum Information About a Proteomics
Experiment
MIAPE (http://www.psidev.info/index.php?q¼node/91) is a project of
the HUPO proteomics standards initiative that establishes the minimum
information that must be reported on a proteomics experiment (where
samples came from, how analyses of them were performed, etc.) so other
authors can reproduce the results of the original work. The requirements of
the various journals also differ, so important details may be lacking in some
cases, or presented in an inappropriate form.
As so, when authors are interested in publish results obtained from
proteomics approaches it is practical and useful to consult the MIAPE
guidelines already published, most information is available at the webpage
http://www.psidev.info/index.php?q¼node/91. Before submitting a paper
for publication it is also essential to consult the requisites of the journal of
interest about the data that authors must present for the type of approach
they have been using in their investigation.ACKNOWLEDGMENTS
The research relevant to this paper was supported by Fundac¸a˜o da Cieˆncia e a Tecnologia
(FCT) e Fundo Europeu de Desenvolvimento Regional (FEDER) research grants POCTI/
MGI/40878/2001 and POCI/SAU-MMO/56163/2004, FCT-Poly-Annual Funding Pro-
gram and FEDER-Sau´de XXI Program, Portugal. PGA was a recipient of FCT-PhD
fellowship SFRH/BD/17744/2004 and SN is a recipient of Ricardo Jorge-research
fellowship.REFERENCES
Aebersold, R., and Mann, M. (2003). Mass spectrometry-based proteomics. Nature 422,
198–207.
232 Patrı´cia Gomes-Alves et al.Bartoszewski, R., et al. (2008). Activation of the unfolded protein response by DeltaF508
CFTR. Am. J. Respir. Cell. Mol. Biol. 39, 448–457.
Bensalem, N., et al. (2007). High sensitivity identification of membrane proteins by MALDI
TOF-MASS spectrometry using polystyrene beads. J. Proteome Res. 6, 1595–1602.
Candiano, G., et al. (2004). Blue silver: A very sensitive colloidal Coomassie G-250 staining
for proteome analysis. Electrophoresis 25, 1327–1333.
Chang, X. B., et al. (1999). Removal of multiple arginine-framed trafficking signals over-
comes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis.
Mol. Cell 4, 137–142.
Chen, L. C., and Casadevall, A. (1999). Labeling of proteins with [35S]methionine and/or
[35S]cysteine in the absence of cells. Anal. Biochem. 269, 179–188.
Citterio, C., et al. (2008). Unfolded protein response and cell death after depletion of
brefeldin A-inhibited guanine nucleotide-exchange protein GBF1. Proc. Natl. Acad.
Sci. USA 105, 2877–2882.
Denning, G. M., et al. (1992). Processing of mutant cystic fibrosis transmembrane conduc-
tance regulator is temperature-sensitive. Nature 358, 761–764.
Gomes-Alves, P., and Penque, D. (2010). Proteomics uncovering possible key players in
F508del-CFTR processing and trafficking. Expert Rev. Proteomics 7, 487–494.
Gomes-Alves, P., et al. (2009). Low temperature restoring effect on F508del-CFTR mis-
processing: A proteomic approach. J Proteomics 73, 218–230.
Gomes-Alves, P., et al. (2010a). Rescue of F508del-CFTR by RXR motif inactivation
triggers proteome modulation associated with the unfolded protein response. Biochim.
Biophys. Acta 1804, 856–865.
Gomes-Alves, P., et al. (2010b). Rescue of F508del-CFTR by RXR motif inactivation
triggers proteome modulation associated with the unfolded protein response. Biochim.
Biophys. Acta Proteins Proteomics 1804, 856–865.
Gorg, A., et al. (2004). Current two-dimensional electrophoresis technology for proteomics.
Proteomics 4, 3665–3685.
Kelsen, S. G., et al. (2008). Cigarette smoke induces an unfolded protein response in the
human lung: A proteomic approach. Am. J. Respir. Cell. Mol. Biol. 38, 541–550.
Kerbiriou, M., et al. (2007). Coupling cystic fibrosis to endoplasmic reticulum stress:
Differential role of Grp78 and ATF6. Biochim. Biophys. Acta. 1772, 1236–1249.
Kitteringham, N. R., et al. (2009). Multiple reaction monitoring for quantitative biomarker
analysis in proteomics and metabolomics. J. Chromatogr. B Analyt. Technol. Biomed. Life
Sci. 877, 1229–1239.
Loo, T. W., et al. (2005). Rescue of folding defects in ABC transporters using pharmaco-
logical chaperones. J. Bioenerg. Biomembr. 37, 501–507.
Mendes, F., et al. (2003). Unusually common cystic fibrosis mutation in Portugal encodes a
misprocessed protein. Biochem. Biophys. Res. Commun. 311, 665–671.
Meunier, B., et al. (2007). Assessment of hierarchical clustering methodologies for proteomic
data mining. J. Proteome Res. 6, 358–366.
Minden, J. (2007). Comparative proteomics and difference gel electrophoresis. Biotechniques
43, 739–745.
Penque, D. (2009). Two-dimensional gel electrophoresis and mass spectrometry for bio-
marker discovery. Proteomics Clin. Appl. 3, 155–172.
Picotti, P., et al. (2010). High-throughput generation of selected reaction-monitoring assays
for proteins and proteomes. Nat. Meth. 7, 43–46.
Powers, E. T., et al. (2009). Biological and chemical approaches to diseases of proteostasis
deficiency. Annu. Rev. Biochem. 78, 959–991.
Rennolds, J., et al. (2008). Low temperature induces the delivery of mature and immature
CFTR to the plasma membrane. Biochem. Biophys. Res. Commun. 366, 1025–1029.
UPR/ER Stress Signalling Pathways Unraveled by Proteomics 233Roxo-Rosa, M., et al. (2004). Proteomics techniques for cystic fibrosis research. J. Cyst.
Fibros. 3(Suppl. 2), 85–89.
Roxo-Rosa, M., et al. (2006). Revertant mutants G550E and 4RK rescue cystic fibrosis
mutants in the first nucleotide-binding domain of CFTR by different mechanisms. Proc.
Natl. Acad. Sci. USA 103, 17891–17896.
Sharma, M., et al. (2001). Conformational and temperature-sensitive stability defects of the
delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic
reticulum compartments. J. Biol. Chem. 276, 8942–8950.
Singh, O. V., et al. (2008). Chemical rescue of deltaF508-CFTR mimics genetic repair in
cystic fibrosis bronchial epithelial cells. Mol. Cell. Proteomics 7, 1099–1110.
Steen, H., and Mann, M. (2004). The ABC’s (and XYZ’s) of peptide sequencing. Nat. Rev.
Mol. Cell. Biol. 5, 699–711.
van Anken, E., and Braakman, I. (2005). Versatility of the endoplasmic reticulum protein
folding factory. Crit. Rev. Biochem. Mol. Biol. 40, 191–228.

